{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T20:12:23Z","timestamp":1786997543748,"version":"build-2736575974"},"reference-count":82,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["cell.com","bmn.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Pharmacological Sciences"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1016\/j.tips.2015.02.006","type":"journal-article","created":{"date-parts":[[2015,3,13]],"date-time":"2015-03-13T01:00:48Z","timestamp":1426208448000},"page":"196-202","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":57,"title":["\u03b12-Adrenoceptors in the treatment of major neuropsychiatric disorders"],"prefix":"10.1016","volume":"36","author":[{"given":"Salomon Z.","family":"Langer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tips.2015.02.006_bib0410","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1016\/0006-2952(74)90187-7","article-title":"Presynaptic regulation of catecholamine release","volume":"23","author":"Langer","year":"1974","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.tips.2015.02.006_bib0415","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1111\/j.1476-5381.1977.tb07526.x","article-title":"Presynaptic receptors and their role in the regulation of transmitter release","volume":"60","author":"Langer","year":"1977","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.tips.2015.02.006_bib0420","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/S0031-6997(25)06843-7","article-title":"Presynaptic regulation of the release of catecholamines","volume":"32","author":"Langer","year":"1981","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.tips.2015.02.006_bib0425","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1152\/physrev.1989.69.3.864","article-title":"Modulation of neurotransmitter release by presynaptic autoreceptors","volume":"69","author":"Starke","year":"1989","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.tips.2015.02.006_bib0430","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0165-6147(96)01034-6","article-title":"25 years since the discovery of presynaptic receptors: present knowledge and future perspectives","volume":"18","author":"Langer","year":"1997","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.tips.2015.02.006_bib0435","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1111\/j.1476-5381.1972.tb07306.x","article-title":"Role of the \u03b1-adrenoceptor in regulating noradrenaline overflow by nerve stimulation","volume":"44","author":"Enero","year":"1972","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.tips.2015.02.006_bib0440","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1111\/j.1476-5381.1974.tb09723.x","article-title":"Protection by phentolamine against the effects of phenoxibenzamine on transmitter release elicited by nerve stimulation in the perfused cat heart","volume":"52","author":"Farah","year":"1974","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.tips.2015.02.006_bib0445","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1038\/265648a0","article-title":"Physiological significance of \u03b1-adrenoceptor-mediated negative feedback mechanism regulating noradrenaline release during nerve stimulation","volume":"265","author":"Langer","year":"1977","journal-title":"Nature"},{"key":"10.1016\/j.tips.2015.02.006_bib0450","series-title":"Receptor-mediated Control of Dopamine Metabolism","first-page":"49","author":"Carlsson","year":"1975"},{"key":"10.1016\/j.tips.2015.02.006_bib0455","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1113\/jphysiol.1974.sp010495","article-title":"Negative feed-back regulation of noradrenaline release by nerve stimulation in the perfused cat's spleen: differences in potency of phenoxibenzamine in blocking the pre- and post-synaptic adrenergic receptors","volume":"237","author":"Dubocovich","year":"1974","journal-title":"J. Physiol."},{"key":"10.1016\/j.tips.2015.02.006_bib0460","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/S0022-3565(25)29938-4","article-title":"Release of norepinephrine and dopamine-beta-hydroxylase by nerve stimulation. I. Role of neuronal and extraneuronal uptake and of \u03b1-presynaptic receptors","volume":"190","author":"Cubeddu","year":"1974","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.tips.2015.02.006_bib0465","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0031-6997(25)06780-8","article-title":"Adrenoceptor subtypes","volume":"46","author":"Bylund","year":"1994","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.tips.2015.02.006_bib0470","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1161\/01.HYP.2.4.372","article-title":"Recent developments in noradrenergic neurotransmission and its relevance to the mechanism of action of certain antihypertensive agents","volume":"2","author":"Langer","year":"1980","journal-title":"Hypertension"},{"key":"10.1016\/j.tips.2015.02.006_bib0475","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1126\/science.482929","article-title":"Dopamine auto- and postsynaptic receptors: electrophysiological evidence for differential sensitivity to dopamine agonists","volume":"206","author":"Skirboll","year":"1979","journal-title":"Science"},{"key":"10.1016\/j.tips.2015.02.006_bib0480","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0014-2999(77)90377-6","article-title":"Substantivity of presynaptic \u03b1-adrenoceptors after exposure to noradrenaline","volume":"41","author":"Langer","year":"1977","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.tips.2015.02.006_bib0485","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/S0022-3565(25)30996-1","article-title":"Subsensitivity of the presynaptic \u03b1 adrenoceptors after short-term surgical denervation of the cat nictitating membrane","volume":"202","author":"Langer","year":"1977","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.tips.2015.02.006_bib0490","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/0006-8993(85)91605-1","article-title":"Rapid desensitization of presynaptic dopamine autoreceptors during exposure to exogenous dopamine","volume":"337","author":"Arbilla","year":"1985","journal-title":"Brain Res."},{"key":"10.1016\/j.tips.2015.02.006_bib0495","first-page":"263","article-title":"Heteroreceptor-mediated modulation of noradrenaline and acetylcholine release from peripheral nerves","volume":"126","author":"Fuder","year":"1995","journal-title":"Rev. Physiol. Biochem. Pharmacol."},{"key":"10.1016\/j.tips.2015.02.006_bib0500","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/BF00501305","article-title":"Inhibition by dopamine of 3H-noradrenaline release elicited by nerve stimulation in the isolated cat's nictitating membrane","volume":"289","author":"Enero","year":"1975","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"key":"10.1016\/j.tips.2015.02.006_bib0505","first-page":"60","article-title":"Frequency-dependence of Serotonin autoreceptor but not \u03b1-2 adrenoceptor inhibition of [3H]- serotonin release in rat hypothalamic slices","volume":"339","author":"Blier","year":"1989","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"key":"10.1016\/j.tips.2015.02.006_bib0510","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/j.1476-5381.1975.tb07328.x","article-title":"Possible role of a beta-adrenoceptor in the regulation of noradrenaline release by nerve stimulation through a positive feed-back mechanism","volume":"53","author":"Adler-Graschinsky","year":"1975","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.tips.2015.02.006_bib0515","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/271559a0","article-title":"Morphine and beta-endorphin inhibit release of noradrenaline from cerebral cortex but not of dopamine from rat striatum","volume":"271","author":"Arbilla","year":"1978","journal-title":"Nature"},{"key":"10.1016\/j.tips.2015.02.006_bib0520","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1111\/j.1476-5381.1980.tb08714.x","article-title":"Pharmacological differentiation of presynaptic inhibitory \u03b1\u2013adrenoceptors and opiate receptors in the cat nictitating membrane","volume":"70","author":"Dubocovich","year":"1980","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.tips.2015.02.006_bib0525","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/S0022-3565(25)31928-2","article-title":"Dopamine and \u03b1 adrenoceptor agonists inhibit neurotransmission in the cat spleen through different presynaptic receptors","volume":"212","author":"Dubocovich","year":"1980","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.tips.2015.02.006_bib0530","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/0006-8993(82)91147-7","article-title":"Muscarinic receptors on dopamine terminals in the cat caudate nucleus: modulation of tritiated dopamine release in vitro by endogenous acetylcholine","volume":"248","author":"Lehmann","year":"1982","journal-title":"Brain Res."},{"key":"10.1016\/j.tips.2015.02.006_bib0535","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/0306-4522(95)00308-6","article-title":"Intercellular communication in the brain: wiring versus volume transmission","volume":"69","author":"Agnati","year":"1995","journal-title":"Neuroscience"},{"key":"10.1016\/j.tips.2015.02.006_bib0540","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1111\/j.1476-5381.2009.00624.x","article-title":"Non-synaptic receptors and transporters involved in brain functions and target of drug development","volume":"160","author":"Vizi","year":"2010","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.tips.2015.02.006_bib0545","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/S0022-3565(25)30464-7","article-title":"Possible involvement of a transmitter different from norepinephrine in the residual responses to nerve stimulation of the cat nictitating membrane after pre-treatment with reserpine","volume":"196","author":"Langer","year":"1976","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.tips.2015.02.006_bib0550","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/0306-4522(76)90054-3","article-title":"Commentary: do some nerve cells release more than one transmitter","volume":"1","author":"Burnstock","year":"1976","journal-title":"Neuroscience"},{"key":"10.1016\/j.tips.2015.02.006_bib0555","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/BF01244098","article-title":"Locus coeruleus neurons show reduced \u03b1-2 receptor responsiveness and decreased basal activity in spontaneously hypertensive rats","volume":"69","author":"Engberg","year":"1987","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.tips.2015.02.006_bib0560","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF00215471","article-title":"Peripheral, autonomic regulation of locus coeruleus noradrenergic neurons in brain: putative implications for psychiatry and psychopharmacology","volume":"92","author":"Svensson","year":"1987","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.tips.2015.02.006_bib0565","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1089\/cap.2013.0028","article-title":"A review of the rationale and clinical utilization of \u03b1-2 adrenoceptor agonists for the treatment of attention-deficit\/hyperactivity and related disorders, Journal of Child and","volume":"23","author":"Sallee","year":"2013","journal-title":"Adolesc. Psychopharmacol."},{"key":"10.1016\/j.tips.2015.02.006_bib0570","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0149-7634(99)00058-5","article-title":"Behavioral validation of the spontaneously hypertensive rat (SRH) as an animal model of attention-deficit\/hyperactivity disorder (AD\/HD)","volume":"24","author":"Sagvolden","year":"2000","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.tips.2015.02.006_bib0575","doi-asserted-by":"crossref","first-page":"4287","DOI":"10.1523\/JNEUROSCI.08-11-04287.1988","article-title":"The A-2 adrenergic agonist guanfacine improves memory in aged monkeys without sedative or hypotensive side effects: evidence for A-2 receptor subtypes","volume":"8","author":"Arnsten","year":"1988","journal-title":"Neuroscience"},{"key":"10.1016\/j.tips.2015.02.006_bib0580","first-page":"45","article-title":"Guanfacine for the treatment of cognitive disorders: a century of discoveries at Yale","volume":"85","author":"Arnsten","year":"2012","journal-title":"Yale J. Biol. Med."},{"key":"10.1016\/j.tips.2015.02.006_bib0585","doi-asserted-by":"crossref","first-page":"3019","DOI":"10.1007\/s00213-014-3479-4","article-title":"Aberrant glutamate signaling in the prefrontal cortex and striatum of the spontaneously hypertensive rat model of attention-deficit\/hyperactivity disorder","volume":"231","author":"Miller","year":"2014","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.tips.2015.02.006_bib0590","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/0014-2999(92)90511-2","article-title":"Presynaptic inhibition by clonidine of neurotransmitter amino acid release in various brain regions","volume":"217","author":"Kamisaki","year":"1992","journal-title":"Eur. J. Pharmacol."},{"issue":"Suppl. 8","key":"10.1016\/j.tips.2015.02.006_bib0595","first-page":"13","article-title":"Use of atypical antipsychotics in refractory depression and anxiety","volume":"66","author":"Nemeroff","year":"2005","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.tips.2015.02.006_bib0600","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.neuron.2005.02.014","article-title":"Deep brain stimulation for treatment-resistant depression","volume":"45","author":"Mayberg","year":"2005","journal-title":"Neuron"},{"key":"10.1016\/j.tips.2015.02.006_bib0610","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1126\/science.213833","article-title":"Feedback inhibition of brain noradrenaline neurons by tricyclic antidepressants: \u03b1-receptor mediation","volume":"202","author":"Svensson","year":"1978","journal-title":"Science"},{"key":"10.1016\/j.tips.2015.02.006_bib0615","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/S0006-3223(99)00126-2","article-title":"Locus coeruleus neuronal activity and noradrenaline availability in the frontal cortex of rats chronically treated with imipramine: effect of \u03b1 2-adrenoceptor blockade","volume":"46","author":"Linn\u00e9r","year":"1999","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.tips.2015.02.006_bib0605","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1038\/275479b0","article-title":"Presynaptic receptors","volume":"275","author":"Langer","year":"1978","journal-title":"Nature"},{"key":"10.1016\/j.tips.2015.02.006_bib0620","first-page":"233","article-title":"Mianserin: direct activation of brain norepinephrine neurons by blocking \u03b1 2-receptors","volume":"4","author":"Engberg","year":"1980","journal-title":"Commun. Psychopharmacol."},{"key":"10.1016\/j.tips.2015.02.006_bib0625","doi-asserted-by":"crossref","first-page":"35","DOI":"10.2165\/11319480-000000000-00000","article-title":"Safety reporting and adverse-event profile of mirtazapine described in randomized controlled trials in comparison with other classes of antidepressants in the acute-phase treatment of adults with depression: systematic review and meta-analysis","volume":"24","author":"Watanabe","year":"2010","journal-title":"CNS Drugs"},{"key":"10.1016\/j.tips.2015.02.006_bib0630","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1177\/026988119200600306","article-title":"The effects and after effects of the \u03b12-adrenoceptor antagonist idazoxan on mood, memory and attention in normal volunteers","volume":"6","author":"Smith","year":"1992","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.tips.2015.02.006_bib0635","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0165-0327(99)00041-5","article-title":"A double-blind study comparing idazoxan and bupropion in bipolar depressed patients","volume":"56","author":"Grossman","year":"1999","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.tips.2015.02.006_bib0640","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1001\/archpsyc.1989.01810100100021","article-title":"Idazoxan: a alpha-2 selective antagonist and effective sustained antidepressant in two Bipolar Depressed patients","volume":"46","author":"Osman","year":"1989","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.tips.2015.02.006_bib0645","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0165-0327(97)00160-2","article-title":"Clozapine in bipolar disorder: treatment implications for other atypical antipsychotics","volume":"48","author":"Frye","year":"1998","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.tips.2015.02.006_bib0650","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/npp.1994.34","article-title":"Plasma clozapine and desmethylclozapine levels in clozapine-induced agranulocytosis","volume":"11","author":"Hasegawa","year":"1994","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.tips.2015.02.006_bib0655","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.jad.2014.03.017","article-title":"Effect of symptom severity on efficacy and safety of aripiprazole adjunctive to antidepressant monotherapy in major depressive disorder: a pooled analysis","volume":"162","author":"Stewart","year":"2014","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.tips.2015.02.006_bib0660","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1016\/j.neubiorev.2012.07.011","article-title":"\u03b12 adrenergic receptor dysregulation in depressive disorders: implications for the neurobiology of depression and antidepressant therapy","volume":"36","author":"Cottingham","year":"2012","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.tips.2015.02.006_bib0665","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.neuropharm.2014.09.018","article-title":"Monoamine receptor agonists, acting preferentially at presynaptic autoreceptors and heteroreceptors, downregulate the cell fate adaptor FADD in rat brain cortex","volume":"89","author":"Garcia-Fuster","year":"2015","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.tips.2015.02.006_bib0670","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1001\/archpsyc.1988.01800330013001","article-title":"Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine","volume":"45","author":"Honigfeld","year":"1988","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.tips.2015.02.006_bib0675","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1001\/archpsyc.60.1.82","article-title":"Clozapine treatment for suicidality in schizophrenia: International Suicide Prevention Trial (InterSept.)","volume":"60","author":"Meltzer","year":"2003","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.tips.2015.02.006_bib0680","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0014-2999(99)00175-2","article-title":"Idazoxan preferentially increases dopamine output in the rat medial prefrontal cortex at the nerve terminal level","volume":"371","author":"Hertel","year":"1999","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.tips.2015.02.006_bib0685","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s00213-002-1381-y","article-title":"Co-release of noradrenaline and dopamine from noradrenergic neurons in the cerebral cortex induced by clozapine, the prototype atypical antipsychotic","volume":"167","author":"Devoto","year":"2003","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.tips.2015.02.006_bib0690","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1126\/science.286.5437.105","article-title":"Enhanced cortical dopamine output and antipsychotic-like effects of raclopride by \u03b12 adrenoceptor blockade","volume":"286","author":"Hertel","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.tips.2015.02.006_bib0695","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1017\/S1461145705005328","article-title":"Combined \u03b12 and D2\/3 receptor blockade enhances cortical glutamatergic transmission and reverses cognitive impairment in the rat","volume":"8","author":"Marcus","year":"2005","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.tips.2015.02.006_bib0700","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1002\/syn.21551","article-title":"Involvement of 5-HT2A and \u03b12 adrenoceptor blockade in the asenapine-induced elevation of prefrontal cortical monoamine outflow","volume":"66","author":"Fr\u00e5nberg","year":"2012","journal-title":"Synapse"},{"key":"10.1016\/j.tips.2015.02.006_bib0705","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.schres.2011.11.030","article-title":"\u03b1-2 receptor antagonist add-on therapy in the treatment of schizophrenia; a meta-analysis","volume":"134","author":"Hecht","year":"2012","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.tips.2015.02.006_bib0710","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1002\/hup.1137","article-title":"More evidence on additive antipsychotic effect of adjunctive mirtazapine in schizophrenia: an extension phase of a randomized controlled trial","volume":"25","author":"Terevnikov","year":"2010","journal-title":"Hum. Psychopharmacol."},{"key":"10.1016\/j.tips.2015.02.006_bib0715","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/BF02246578","article-title":"The \u03b1(2) antagonist idazoxan remediates certain attentional and executive dysfunction in patients with dementia of frontal type","volume":"123","author":"Coull","year":"1996","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.tips.2015.02.006_bib0720","doi-asserted-by":"crossref","first-page":"e322","DOI":"10.1016\/j.jns.2013.07.1199","article-title":"Safety and efficacy of OM-12741 on cognitive and behavioral symptoms in patients with Alzheimer's disease: a randomized, double-blind, proof-of-concept study","volume":"333","author":"Rinne","year":"2013","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.tips.2015.02.006_bib0725","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1111\/j.2042-7158.1972.tb09104.x","article-title":"Evidence for a receptor-mediated feedback control of striatal tyrosine hydroxylase activity","volume":"24","author":"Kehr","year":"1972","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.tips.2015.02.006_bib0730","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/BF00498834","article-title":"Dopaminergic neurons: an in vivo system for measuring drug interactions with presynaptic receptors","volume":"296","author":"Walters","year":"1976","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"key":"10.1016\/j.tips.2015.02.006_bib0735","first-page":"279","article-title":"Piribedil and apomorphine: pre- and postsynaptic effects on dopamine synthesis and neuronal activity","volume":"9","author":"Walters","year":"1975","journal-title":"Adv. Neurol."},{"key":"10.1016\/j.tips.2015.02.006_bib0740","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/S0022-3565(25)38969-X","article-title":"Regulation of dopamine synthesis in the medial prefrontal cortex is mediated by release modulating autoreceptors: studies in vivo","volume":"236","author":"Galloway","year":"1986","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.tips.2015.02.006_bib0745","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/S0022-3565(24)29217-X","article-title":"M2 muscarinic autoreceptors modulate acetylcholine release in prefrontal cortex of C57BL\/6J mouse","volume":"299","author":"Douglas","year":"2001","journal-title":"Pharmacol. Exp. Ther."},{"key":"10.1016\/j.tips.2015.02.006_bib0750","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1177\/026988110001400208","article-title":"Serotonin autoreceptor function and antidepressant drug function","volume":"14","author":"Hjorth","year":"2000","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.tips.2015.02.006_bib0755","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1111\/j.1476-5381.2012.01913.x","article-title":"The histamine autoreceptor is a short isoform of the H3 receptor","volume":"166","author":"Gbahou","year":"2012","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.tips.2015.02.006_bib0760","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1152\/jn.00813.2011","article-title":"Kinetics of GABAB autoreceptor-mediated suppression of GABA release in rat insular cortex","volume":"5","author":"Kobayashi","year":"2012","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.tips.2015.02.006_bib0765","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/nrn2379","article-title":"Presynaptic glutamate receptors: physiological functions and mechanisms of action","volume":"9","author":"Pinheiro","year":"2008","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.tips.2015.02.006_bib0770","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1016\/S0028-3908(99)00223-3","article-title":"Metabotropic glutamate autoreceptors of the mGlu(5) subtype positively modulate neuronal glutamate release in the rat forebrain in vitro","volume":"29","author":"Thomas","year":"2000","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.tips.2015.02.006_bib0775","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1146\/annurev.neuro.22.1.443","article-title":"Presynaptic Ionotropic receptors and the control of transmitter release","volume":"22","author":"MacDermott","year":"1999","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1016\/j.tips.2015.02.006_bib0780","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1358\/dot.2010.46.5.1450095","article-title":"Guanfacine extended release in the treatment of attention deficit hyperactivity disorder in children and adolescents","volume":"46","author":"Connor","year":"2010","journal-title":"Drugs Today"},{"issue":"Suppl. 2","key":"10.1016\/j.tips.2015.02.006_bib0785","doi-asserted-by":"crossref","first-page":"263S","DOI":"10.1111\/j.1365-2125.1983.tb05874.x","article-title":"The pharmacology of mianserin, an update","volume":"15","author":"Marshall","year":"1983","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.tips.2015.02.006_bib0790","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3109\/08039489109096678","article-title":"Mianserin: pharmacological and clinical correlates","volume":"45","author":"Pinder","year":"1991","journal-title":"Nord. J. Psychiatry"},{"key":"10.1016\/j.tips.2015.02.006_bib0795","doi-asserted-by":"crossref","first-page":"607","DOI":"10.2165\/00003495-199957040-00010","article-title":"Mirtazapine: a review of its use in major depression","volume":"57","author":"Holm","year":"1999","journal-title":"Drugs"},{"key":"10.1016\/j.tips.2015.02.006_bib0800","first-page":"483","article-title":"Asenapine monotherapy in the acute treatment of both schizophrenia and bipolar I disorder","volume":"5","author":"Bishara","year":"2009","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.tips.2015.02.006_bib0805","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.2165\/00003495-200161140-00014","article-title":"Amisulpride: a review of its use in the management of schizophrenia","volume":"61","author":"Curran","year":"2001","journal-title":"Drugs"},{"key":"10.1016\/j.tips.2015.02.006_bib0810","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1001\/archpsyc.60.7.681","article-title":"Aripiprazole, an antipsychotic with a novel mechanism of action and risperidone vs placebo in patients with schizophrenia and schizoaffective disorder","volume":"60","author":"Potkin","year":"2003","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.tips.2015.02.006_bib0815","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/0006-8993(75)90276-0","article-title":"Inhibition of both noradrenergic and serotonergic neurons in brain by the a-adrenergic agonist clonidine","volume":"92","author":"Svensson","year":"1975","journal-title":"Brain Res."}],"container-title":["Trends in Pharmacological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165614715000255?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165614715000255?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T19:18:09Z","timestamp":1747768689000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165614715000255"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4]]},"references-count":82,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,4]]}},"alternative-id":["S0165614715000255"],"URL":"https:\/\/doi.org\/10.1016\/j.tips.2015.02.006","relation":{},"ISSN":["0165-6147"],"issn-type":[{"value":"0165-6147","type":"print"}],"subject":[],"published":{"date-parts":[[2015,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"\u03b12-Adrenoceptors in the treatment of major neuropsychiatric disorders","name":"articletitle","label":"Article Title"},{"value":"Trends in Pharmacological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tips.2015.02.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}